Nephros (NEPH) Other Accumulated Expenses (2011 - 2025)

Nephros' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $75000.0 for Q4 2025.

• On a quarterly basis, Other Accumulated Expenses rose 41.51% year-over-year to $75000.0 in Q4 2025; TTM through Dec 2025 was $75000.0, a 41.51% increase from a year earlier, with the FY2025 full-year figure at $75000.0, up 41.51% from the prior year.
• Other Accumulated Expenses advanced to $75000.0 in Q4 2025 per NEPH's latest filing, from $53000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $94000.0 in Q4 2021 and bottomed at $26000.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $75000.0 (2025), against an average of $68400.0.
• Across the five-year window, Other Accumulated Expenses tumbled 72.34% in 2022 and soared 261.54% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $94000.0 in 2021, then plunged by 72.34% to $26000.0 in 2022, then surged by 261.54% to $94000.0 in 2023, then tumbled by 43.62% to $53000.0 in 2024, then surged by 41.51% to $75000.0 in 2025.
• Per Business Quant, the three latest NEPH Other Accumulated Expenses figures stand at $75000.0 (Q4 2025), $53000.0 (Q4 2024), and $94000.0 (Q4 2023).